Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Vincelette

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|December 29, 2010
Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertensionLe-Ning Zhang, Jon Vincelette, Dawn Chen, et al.
Thrombosis Research|June 10, 2008
Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (II): pharmacodynamic and pharmacokinetic characterizationJoseph M Post, Serene Alexander, Yi-Xin Wang, et al.
Thrombosis and Haemostasis|November 16, 2004
P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1Ningzheng Dong, Valdeci Da Cunha, Andrej Citkowicz, et al.
European Journal of Pharmacology|April 21, 2005
Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient miceYi-Xin Wang, Valdeci da Cunha, Baby Martin-McNulty, et al.
Journal of Vascular Surgery|August 8, 2006
Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosisValdeci da Cunha, Baby Martin-McNulty, Jon Vincelette, et al.
Thrombosis and Haemostasis|January 4, 2007
A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosisYi-Xin Wang, Valdeci da Cunha, Jon Vincelette, et al.
Thrombosis and Haemostasis|January 4, 2007
A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - part I: pharmacological characterizationYi-Xin Wang, Lei Zhao, Mariko Nagashima, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 17, 2007
Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c miceYi-Xin Wang, Valdeci da Cunha, Jon Vincelette, et al.
Journal of Alzheimer'S Disease : JAD|April 11, 2016
Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's DiseasePatricia R Spilman, Veronique Corset, Olivia Gorostiza, et al.
The Journal of Biological Chemistry|July 31, 2020
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|December 29, 2010
Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertensionLe-Ning Zhang, Jon Vincelette, Dawn Chen, et al.
Thrombosis Research|June 10, 2008
Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (II): pharmacodynamic and pharmacokinetic characterizationJoseph M Post, Serene Alexander, Yi-Xin Wang, et al.
Thrombosis and Haemostasis|November 16, 2004
P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1Ningzheng Dong, Valdeci Da Cunha, Andrej Citkowicz, et al.
European Journal of Pharmacology|April 21, 2005
Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient miceYi-Xin Wang, Valdeci da Cunha, Baby Martin-McNulty, et al.
Journal of Vascular Surgery|August 8, 2006
Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosisValdeci da Cunha, Baby Martin-McNulty, Jon Vincelette, et al.
Thrombosis and Haemostasis|January 4, 2007
A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosisYi-Xin Wang, Valdeci da Cunha, Jon Vincelette, et al.
Thrombosis and Haemostasis|January 4, 2007
A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - part I: pharmacological characterizationYi-Xin Wang, Lei Zhao, Mariko Nagashima, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 17, 2007
Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c miceYi-Xin Wang, Valdeci da Cunha, Jon Vincelette, et al.
Journal of Alzheimer'S Disease : JAD|April 11, 2016
Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's DiseasePatricia R Spilman, Veronique Corset, Olivia Gorostiza, et al.
The Journal of Biological Chemistry|July 31, 2020
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
Pageof 3